PubMed Health⌕ Search

Biomedical subjects

E Capelli

Publications and source records attributed to E Capelli.

27 records · Page 2Linked to original sources

HLA class I molecules expression: evaluation of different immunocytochemical methods in malignant lesions.

It is generally accepted that human and experimental tumour cells can lose Major Histocompatibility Complex (MHC) class I molecules and this represents the major mechanism of tumour escape from T-cell immune responses. Nevertheless testing of HL4 class I antigen expression in malignant lesions is not routinely used to evaluate the immunological conditions of the patients because of the pathologists' reluctance to utilise frozen tissue sections in immunocytochemisty. We analysed the expressions of HLA class I molecule and beta2-microglobulin in normal and neoplastic tissues, comparing different samples and methods. The expression of HLA receptors was studied in 7 brain tumours, 10 colon adenocarcinoma and 2 breast carcinoma by immunocytochemical technique. 4 normal tissues and peripheral blood mononucleated cells were analysed as positive control. The peroxidase staining method was performed on fresh imprints, frozen sections, formalin- fixed tissues and fine-needle aspirates. The results indicated that the best and simplest conditions for the detection of HLA molecules were obtained using fresh imprints and fine-needle aspirates.

Adenocarcinoma↗

Factors leading to the appearance, after BMT, of cytotoxic antibodies against T, B and activated T lymphocytes: critical appraisal.

In order to investigate the role of lymphocytotoxic antibodies, acquired after allogeneic and autologus bone marrow transplantation, we studied 309 sera from 42 transplanted patients (16 adults and 26 children). We tried to correlate antibody elicitation towards T, B and activated T lymphocytes with the following parameters: genetic (recipient's and donor's sex, HLA profile), clinical (recipient's primary disease, GvHD, transplant outcome) and technical (bone marrow purging, auto-or allotransplant). There is evidence that anti-T and -B cytotoxic antibodies appear earlier than anti-activated T antibodies. Anti-HLA specific antibodies seem to be produced by the transfusional stimulus: they appear early after BMT and wane after the first year. Humoral responsiveness seems to be age related (adults are more responsive than children) and conditioned by GvHD (the level of cytotoxic antibodies decreases when GvHD is prevented by bone marrow purging). The level of cytotoxicity is significantly lower in the sera of autotransplanted patients compared with the allotransplanted ones. It appears that anti-activated T antibodies are produced by cell activation at different times in adults and children: in adults this occurs during GVHD and in children during the relapse of disease.

Adolescent↗

DNA-protein cell content of lymphokine activated killer (LAK) and target cells in coculture.

An extensive study of the interactions between LAK-target cells in cocultures was performed by means of cytometric (relative DNA and protein content) and morphological parameters. The aim was to obtain new information about the cell cycle stage of tumor target cells (Chang line) during the attack of LAK cells. Specimens obtained from cocultures at 0, 24, 48 hours were processed for electron microscopy, flow cytometry, immunocytochemistry (anti-BrdU reaction) and light microscopy (L.I., M.I., cell-cell interaction). The most intense activity of LAK cells against the target was found at 24 hours of coculture independently of the proliferative stage of the tumor cells. These results suggest that the high affinity between killer and target cells was not affected by the molecular changes of the Chang cell surface during the cell cycle.

Cell Communication↗

Morphofunctional characterization of lymphokine activated killer (LAK) cells in vitro.

In order to characterize the cellular subsets of peripheral blood lymphocytes cultured with interleukin-2 (IL-2), a study in vitro was developed. Both conditioned medium from PHA-stimulated lymphocytes and recombinant IL-2 (rIL-2) were employed. The following aspects were examined: the morphological pattern of IL-2 stimulated lymphocytes; the ability of these cells to recognize, bind, attack and destroy tumoral lines; their cytochemical and immunological (CD) feature. The results suggest that, in our experimental conditions, these cells showed a characteristic "hand mirror shape", cytotoxic antitumor activity, lack of hydrolytic enzymes and CD3+, CD4+ phenotype.

Cells, Cultured↗

Cell activation and death (apoptosis) induced by IL-2: ultrastructural evidence.

Peripheral blood cells of cancer patients with advanced renal carcinoma and treated with interleukin-2 by intravenous application were studied by electron microscopy at different intervals from the beginning of rIL-2 administration. Morphofunctional modifications of lymphocytes, circulating hystiocytes containing phagocitated bodies and polimorphonucleated cells undergoing phagocytosis were observed with a time dependent increase of altered cells. The analysis of blood cells cultured in the presence of recombinant IL-2 confirmed the in vivo results. Our data suggest that IL-2 induces apoptotic phenomena in the peripheral blood cells of treated patients.

Apoptosis↗

Activated lymphoid cells in human gliomas: morphofunctional and cytochemical evidence.

To study defensive infiltrating cells, smear preparation from 20 fresh gliomas and autologous normal peritumoural brain tissue, used as control, were analysed. May-Grünwald Giemsa staining and cytochemical reaction markers of cellular functions [acid phosphatase (AP), dihydrofolate reductase (DHFR), dipeptidilpeptidase (DAP IV) and serine esterase BLT-dependent (SE)], were employed to characterize the cells. The extent of the leukocytic infiltration and the percentage of activated lymphocytes ("hand mirror" shape lymphocytes: HMS; lymphocytes binding tumor: LBT) were also studied. In addition serum levels of T cell growth factor interleukin-2 (IL-2) and of the soluble IL-2 receptor (sIL-2R) were determined in the affected patients. In tumoural imprints, mostly in astrocytomas, we observed an increased percentage of DHFR and DAP IV positive lymphocytes, of HMS lymphocytes and of lymphocytes binding tumoral cells. Serum levels of IL-2 were significantly increased in all patients whilst sIL-2R levels, were high only in glioblastoma. These findings indicate that in malignant gliomas there is stimulation of the immune system as witnessed by the presence of activated cells inside tumor tissue and soluble activating factors in serum.

Acid Phosphatase↗

Effects of interleukin-2 for the treatment of malignant mesothelioma.

The hematological profile, and clinical parameters in mesothelioma affected patients undergoing a clinical trial to evaluate the efficacy of IL-2 treatment were investigated. Six patients were monitored for 6 weeks following therapy. Blood cell count, morphological and immunophenotypical analysis were performed, as well as clinical evaluations of the patients before and after therapy. Activation of the immune system (increase in lymphocytes, monocytes, eosinophils and HMS lymphocytes) induced by IL-2 was observed. The treatment was well tolerated: our patients had only mild adverse reactions controlled by symptomatic therapy. Eosinophilia represented the most evident negative effect. A slight decrease in CD4-positive subset of lymphocytes was observed after rIL-2 treatment. The therapy did not induce significant changes in the progression of the disease. In one patient necrosis at the tumoral site was observed after loco-regional rIL-2 administration.

Blood Cell Count↗